GSK Consumer Healthcare brings latest allergy switch to retail with Flonase Sensimist

WARREN, N.J. — GSK Consumer Healthcare on Wednesday announced the nationwide launch of Flonase Sensimist Allergy Relief (fluticasone furoate, 27.5 mcg spray), a new over-the-counter treatment for symptoms associated with seasonal and perennial allergies.



“GSK Consumer Healthcare has a strong heritage in discovering and developing respiratory products to meet patient needs worldwide,” stated Jennifer Nadelson, senior brand manager, Flonase. “With Flonase Sensimist, we’re proud to offer allergy sufferers an additional product option providing more complete symptom reliefi in a new, unique, user-friendly device.”



“For the more than 50 million Americans who suffer from allergies, the burden is more than just a stuffy nose,” added Clifford Bassett, medical director of Allergy & Asthma Care of New York. “Uncontrolled allergies have a measurable impact on quality of life, affecting children and adults. In my patient population, having a proactive treatment plan in place makes a big difference in managing their allergies.”



With unique MistPro technology, Flonase Sensimist delivers a fine, gentle, yet powerful mist spray, providing non-drowsy, 24-hour relief of allergy symptoms including itchy, watery eyes, nasal congestion, runny or itchy nose and sneezing.  



Taken once daily, directly in the nose, Flonase Sensimist protects against allergies caused by triggers including pollen, mold, dust and pets. Flonase Sensimist helps block six key inflammatory substances and has been found to be 40% stronger than a leading non-drowsy allergy pill, GSK Consumer Healthcare noted.